Englander Institute for Precision Medicine

Cancer stem cell immunoediting by IFNγ.

TitleCancer stem cell immunoediting by IFNγ.
Publication TypeJournal Article
Year of Publication2023
AuthorsGalassi C, Galluzzi L
JournalCell Death Dis
Volume14
Issue8
Pagination538
Date Published2023 Aug 21
ISSN2041-4889
KeywordsHumans, Neoplasms
Abstract

The secretion of interferon gamma (IFNG, best known as IFNγ) by immune effector cells generally mediates potent anticancer effects. Recent data from Beziaud et al. demonstrate that—at least in some circumstances—IFNγ can edit the breast cancer microenvironment to promote stemness, disease progression and resistance to (immuno)therapy.

DOI10.1038/s41419-023-06079-2
Alternate JournalCell Death Dis
PubMed ID37604810
PubMed Central IDPMC10442329
Grant ListU54 CA274291 / CA / NCI NIH HHS / United States
R01 CA271915 / CA / NCI NIH HHS / United States

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021